Flumazenil for the reversal of refractory benzodiazepine-induced shock

Wendy Coates; Timothy C. Evans; Dietrich Jehle; Fred Harchelroad; Marshal Isaacs

doi:10.3109/15563659109025752

Flumazenil for the reversal of refractory benzodiazepine-induced shock

Wendy Coates
, Timothy C. Evans
, Dietrich Jehle
, Fred Harchelroad
, Marshal Isaacs

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Benzodiazepines are known to cause central nervous system and centrally mediated cardiovascular depression. The benzodiazepine antagonist flumazenil has been shown to antagonize benzodiazepine-induced central nervous system depression. We report a case in which cardiovascular depression secondary to benzodiazepine use was reversed by this agent.

Original language	English (US)
Pages (from-to)	537-542
Number of pages	6
Journal	Clinical Toxicology
Volume	29
Issue number	4
DOIs	https://doi.org/10.3109/15563659109025752
State	Published - 1991
Externally published	Yes

Keywords

Benzodiazepine-induced shock
Flumazenil

ASJC Scopus subject areas

Toxicology

Access to Document

10.3109/15563659109025752

Cite this

@article{3876792d43424894985c3c6d7f3c6c01,

title = "Flumazenil for the reversal of refractory benzodiazepine-induced shock",

abstract = "Benzodiazepines are known to cause central nervous system and centrally mediated cardiovascular depression. The benzodiazepine antagonist flumazenil has been shown to antagonize benzodiazepine-induced central nervous system depression. We report a case in which cardiovascular depression secondary to benzodiazepine use was reversed by this agent.",

keywords = "Benzodiazepine-induced shock, Flumazenil",

author = "Wendy Coates and Evans, \{Timothy C.\} and Dietrich Jehle and Fred Harchelroad and Marshal Isaacs",

year = "1991",

doi = "10.3109/15563659109025752",

language = "English (US)",

volume = "29",

pages = "537--542",

journal = "Clinical Toxicology",

issn = "1556-3650",

publisher = "Taylor and Francis Ltd.",

number = "4",

}

TY - JOUR

T1 - Flumazenil for the reversal of refractory benzodiazepine-induced shock

AU - Coates, Wendy

AU - Evans, Timothy C.

AU - Jehle, Dietrich

AU - Harchelroad, Fred

AU - Isaacs, Marshal

PY - 1991

Y1 - 1991

N2 - Benzodiazepines are known to cause central nervous system and centrally mediated cardiovascular depression. The benzodiazepine antagonist flumazenil has been shown to antagonize benzodiazepine-induced central nervous system depression. We report a case in which cardiovascular depression secondary to benzodiazepine use was reversed by this agent.

AB - Benzodiazepines are known to cause central nervous system and centrally mediated cardiovascular depression. The benzodiazepine antagonist flumazenil has been shown to antagonize benzodiazepine-induced central nervous system depression. We report a case in which cardiovascular depression secondary to benzodiazepine use was reversed by this agent.

KW - Benzodiazepine-induced shock

KW - Flumazenil

UR - https://www.scopus.com/pages/publications/0026337708

UR - https://www.scopus.com/pages/publications/0026337708#tab=citedBy

U2 - 10.3109/15563659109025752

DO - 10.3109/15563659109025752

M3 - Article

C2 - 1749058

AN - SCOPUS:0026337708

SN - 1556-3650

VL - 29

SP - 537

EP - 542

JO - Clinical Toxicology

JF - Clinical Toxicology

IS - 4

ER -

Flumazenil for the reversal of refractory benzodiazepine-induced shock

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this